Acorda Therapeutics
Delaware corporation
Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija and Ampyra (dalfampridine) in the United States.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 55 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
—
not enough monitored evidence
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
—
not enough monitored evidence
1 active sensor·1 observation·0 historical changes·0 structured events·historical coverage 83 %·observed since 2026-09-13
Compare Acorda Therapeutics with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies